Mr. Jose N. Valencia, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2536 Rockwood Ave Ste 102, Calexico, CA 92231 Phone: 760-768-3422 |
Reactivate Physical Therapy Inc Physical Therapist Medicare: Medicare Enrolled Practice Location: 2451 Rockwood Ave Ste 101, Calexico, CA 92231 Phone: 442-271-8532 |
Mr. Shyam Sukumar Ullal, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 408 E 3rd St, Calexico, CA 92231 Phone: 760-357-8864 Fax: 760-357-8866 |
Dinah Compton Physical Therapist Medicare: Medicare Enrolled Practice Location: 2300 N Imperial Ave Ste H, Calexico, CA 92231 Phone: 760-890-7050 |
Dustin Lee Bonham, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2536 Rockwood Ave, Calexico, CA 92231 Phone: 760-768-3422 Fax: 760-768-8408 |
Rhiannon Comia, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2300 N Imperial Ave Ste H, Calexico, CA 92231 Phone: 760-890-7050 Fax: 877-298-4204 |
Prn Desert Rehabilitation Institute Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2536 Rockwood Ave, Calexico, CA 92231 Phone: 760-768-3422 Fax: 760-768-8408 |
Orlando Caleb Vazquez, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2451 Rockwood Ave Ste 101, Calexico, CA 92231 Phone: 760-890-5868 Fax: 760-890-5780 |
News Archive
A new weakness has been discovered in cancer cells that may make them more susceptible to chemotherapy and other treatments. In a research report appearing in the September 2013 issue of The FASEB Journal, scientists identify the HDAC5 protein as being essential for the maintenance of structures, called telomeres, within cancer cells that promote cancer cells longevity.
Born and raised in a rural village in Northern Ghana, Dr. Braimah Apambire knows the value of resources in a critically deprived country.
As part of its commitment to innovation and improving patient outcomes, Boston Scientific Corporation has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System in underserved patient populations, including women and people of color.
New research from the University of Bristol brings stem cell therapies for heart disease one step closer. The findings reveal that our bodies' ability to respond to an internal 'mayday' signal may hold the key to success for long-awaited regenerative medicine.
› Verified 7 days ago